Key facts
- This page summarizes Patrick J. Heron's Form 4 filing for Imago BioSciences, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 19 Jul 2021, 16:10.
Patrick J. Heron - 15 Jul 2021 Form 4 Insider Report for Imago BioSciences, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 15 Jul 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Jul 2021, 16:10:23 UTC
- Prior SEC filing
- 11 Jun 2021
- Next SEC filing
- 20 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Hugh Rienhoff, as Attorney-in-fact for Patrick J. Heron
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick J. Heron filed Form 4 for Imago BioSciences, Inc. on 19 Jul 2021.
Change
- Previous filing in this sequence was filed on 11 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMGO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +23,809
- Change %
- Price
- $0.000000
- Shares after
- 23,809
- Date
- 15 Jul 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,809
- Exercise price
- $16.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
One thirty-sixth (1/36th) of the shares initially subject to the option will vest on each monthly anniversary measured from July 15, 2021 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.